(Q52874559)

English

Anti-CGRP antibodies: a new approach to migraine prevention.

scientific article published on 10 August 2014

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/25127171

title

Anti-CGRP antibodies: a new approach to migraine prevention. (English)

1 reference

stated in

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/25127171

1 reference

Uwe Reuter

1

1 reference

stated in

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/25127171

publication date

10 August 2014

1 reference

stated in

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/25127171

published in

Lancet Neurology

1 reference

stated in

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/25127171

volume

13

1 reference

stated in

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/25127171

issue

9

1 reference

stated in

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/25127171

page(s)

857-859

1 reference

stated in

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/25127171

cites work

Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970126-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970126-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970126-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970126-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970126-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of cortical spreading depression in migraine prophylaxis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970126-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970126-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S1474-4422(14)70126-7

1 reference

stated in

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/25127171

PubMed ID

25127171

1 reference

stated in

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/25127171

(Q52874559)

Anti-CGRP antibodies: a new approach to migraine prevention.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)